Since the initial reports, there are numerous studies confirming the utility of CSF Aβ42 and both total and phosphorylated Tau in the diagnostics of AD by providing high sensitivity and specificity, greater than 85%, when comparing AD patients and healthy controls [11]. This evidence concerns the gene MAPT and Alzheimer disease.